Network·Venture Capital
Palo Santo invests in next-generation neuroscience companies developing breakthrough therapeutics and technologies for mental health, with focus on psychedelic therapeutics and novel CNS targets.
This profile has not yet been verified by the firm. Information may be incomplete or outdated. Claim this profile to take control of your listing.
Claim this profile to complete your information, set investment criteria, and start receiving curated deal flow from sponsors on Dealithic.